eCite Digital Repository
Interplay between transcription factors and the epigenome: insight from the role of RUNX1 in leukemia
Citation
Brettingham-Moore, KH and Taberlay, PC and Holloway, AF, Interplay between transcription factors and the epigenome: insight from the role of RUNX1 in leukemia, Frontiers in Immunology, 6 Article 499. ISSN 1664-3224 (2015) [Refereed Article]
 | PDF 426Kb |
Copyright Statement
© 2015 Brettingham-Moore, Taberlay and Holloway. Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) http://creativecommons.org/licenses/by/4.0/
DOI: doi:10.3389/fimmu.2015.00499
Abstract
The genome has the ability to respond in a precise and co-ordinated manner to cellular signals. It achieves this through the concerted actions of transcription factors and the chromatin platform, which are targets of the signaling pathways. Our understanding of the molecular mechanisms through which transcription factors and the chromatin landscape each control gene activity has expanded dramatically over recent years, and attention has now turned to understanding the complex, multifaceted interplay between these regulatory layers in normal and disease states. It has become apparent that transcription factors as well as the components and modifiers of the epigenetic machinery are frequent targets of genomic alterations in cancer cells. Through the study of these factors, we can gain unique insight into the dynamic interplay between transcription factors and the epigenome, and how their dysregulation leads to aberrant gene expression programs in cancer. Here, we will highlight how these factors normally co-operate to establish and maintain the transcriptional and epigenetic landscape of cells, and how this is reprogramed in cancer, focusing on the RUNX1 transcription factor and oncogenic derivative RUNX1-ETO in leukemia as paradigms of transcriptional and epigenetic reprograming.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | epigenome, chromatin, cancer, epigenetic mechanisms, RUNX1, cancer epigenetics |
| Research Division: | Biological Sciences |
| Research Group: | Genetics |
| Research Field: | Epigenetics (incl. genome methylation and epigenomics) |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Clinical health not elsewhere classified |
| UTAS Author: | Brettingham-Moore, KH (Dr Kate Brettingham-Moore) |
| UTAS Author: | Taberlay, PC (Associate Professor Phillippa Taberlay) |
| UTAS Author: | Holloway, AF (Professor Adele Holloway) |
| ID Code: | 107823 |
| Year Published: | 2015 |
| Web of Science® Times Cited: | 21 |
| Deposited By: | Menzies Institute for Medical Research |
| Deposited On: | 2016-03-25 |
| Last Modified: | 2017-11-02 |
| Downloads: | 177 View Download Statistics |
Repository Staff Only: item control page